nasal spray News
Most Popular nasal spray Story
Meda shells out $800M for MedPointe
Sweden's Meda has purchased U.S.-based MedPointe in an $800 million cash and stock deal. Meda said that MedPointe's products, which focus on the areas of allergy, respiratory and pain, are a perfect... Read more...
Latest Headlines
- April 23, 2008
- November 7, 2007
- July 20, 2007
- December 5, 2006
- August 14, 2006
- March 2, 2006
- March 1, 2006
- February 1, 2006
- December 6, 2005
- November 30, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
